[1] Tritos NA, Biller BMK. Current management of Cushing's disease[J]. J Intern Med, 2019, 286:526-541. [2] Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M. Diagnosis and complications of Cushing's syndrome:a consensus statement[J]. J Clin Endocrinol Metab, 2003, 88:5593-5602. [3] Clayton RN, Raskauskiene D, Reulen RC, Jones PW. Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK:audit and meta-analysis of literature[J]. J Clin Endocrinol Metab, 2011, 96:632-642. [4] Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA, Boscaro M. Treatment of adrenocorticotropin-dependent Cushing's syndrome:a consensus statement[J]. J Clin Endocrinol Metab, 2008, 93:2454-2462. [5] Petersenn S, Beckers A, Ferone D, van der Lely A, Bollerslev J, Boscaro M, Brue T, Bruzzi P, Casanueva FF, Chanson P, Colao A, Reincke M, Stalla G, Tsagarakis S. Therapy of endocrine disease:outcomes in patients with Cushing's disease undergoing transsphenoidal surgery:systematic review assessing criteria used to define remission and recurrence[J]. Eur J Endocrinol, 2015, 172:R227-239. [6] Aranda G, Enseñat J, Mora M, Puig-Domingo M, Martínez de Osaba MJ, Casals G, Verger E, Ribalta MT, Hanzu FA, Halperin I. Long-term remission and recurrence rate in a cohort of Cushing's disease:the need for long-term follow-up[J]. Pituitary, 2015, 18:142-149. [7] Feng M, Liu Z, Liu X, Bao X, Yao Y, Deng K, Xing B, Lian W, Zhu H, Lu L, Wang R. Diagnosis and outcomes of 341 patients with Cushing's disease following transsphenoid surgery:a single-center experience[J]. World Neurosurg, 2018, 109:e75-80. [8] Alwani RA, de Herder WW, van Aken MO, van den Berge JH, Delwel EJ, Dallenga AH, De Jong FH, Lamberts SW, van der Lely AJ, Feelders RA. Biochemical predictors of outcome of pituitary surgery for Cushing's disease[J]. Neuroendocrinology, 2010, 91:169-178. [9] Abdelmannan D, Chaiban J, Selman WR, Arafah BM. Recurrences of ACTH-secreting adenomas after pituitary adenomectomy can be accurately predicted by perioperative measurements of plasma ACTH levels[J]. J Clin Endocrinol Metab, 2013, 98:1458-1465. [10] Abu Dabrh AM, Singh Ospina NM, Al Nofal A, Farah WH, Barrionuevo P, Sarigianni M, Mohabbat AB, Benkhadra K, Carranza Leon BG, Gionfriddo MR, Wang Z, Mohammed K, Ahmed AT, Elraiyah TA, Haydour Q, Alahdab F, Prokop LJ, Murad MH. Predictors of biochemical remission and recurrence after surgical and radiation treatments of cushing disease:a systematic review and meta-analysis[J]. Endocr Pract, 2016, 22:466-475. [11] Hameed N, Yedinak CG, Brzana J, Gultekin SH, Coppa ND, Dogan A, Delashaw JB, Fleseriu M. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation:a large single center experience[J]. Pituitary, 2013, 16:452-458. [12] Lambert JK, Goldberg L, Fayngold S, Kostadinov J, Post KD, Geer EB. Predictors of mortality and long-term outcomes in treated Cushing's disease:a study of 346 patients[J]. J Clin Endocrinol Metab, 2013, 98:1022-1030. [13] Roelfsema F, Biermasz NR, Pereira AM. Clinical factors involved in the recurrence of pituitary adenomas after surgical remission:a structured review and meta-analysis[J]. Pituitary, 2012, 15:71-83. [14] Dai C, Fan Y, Liu X, Bao X, Yao Y, Wang R, Feng M. Predictors of immediate remission after surgery in Cushing's disease patients:a large retrospective study from a single center[J]. Neuroendocrinology, 2020. [Epub ahead of print] [15] Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of Cushing's syndrome:an Endocrine Society Clinical Practice Guideline[J]. J Clin Endocrinol Metab, 2008, 93:1526-1540. [16] Bertagna X, Guignat L, Groussin L, Bertherat J. Cushing's disease[J]. Best Pract Res Clin Endocrinol Metab, 2009, 23:607-623. [17] Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A; Endocrine Society. Treatment of Cushing's syndrome:an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2015, 100:2807-2831. [18] Fan Y, Li Y, Li Y, Feng S, Bao X, Feng M, Wang R. Development and assessment of machine learning algorithms for predicting remission after transsphenoidal surgery among patients with acromegaly[J]. Endocrine, 2020, 67:412-422. [19] Ioachimescu AG. Prognostic factors of long-term remission after surgical treatment of Cushing's disease[J]. Endocrinol Metab Clin North Am, 2018, 47:335-347. [20] Valderrábano P, Aller J, García-Valdecasas L, García-Uría J, Martín L, Palacios N, Estrada J. Results of repeated transsphenoidal surgery in Cushing's disease:long-term follow-up[J]. Endocrinol Nutr, 2014, 61:176-183. [21] Asuzu D, Chatain GP, Hayes C, Benzo S, McGlotten R, Keil M, Beri A, Sharma ST, Nieman L, Lodish M, Stratakis C, Lonser RR, Oldfield EH, Chittiboina P. Normalized early postoperative cortisol and ACTH values predict nonremission after surgery for Cushing disease[J]. J Clin Endocrinol Metab, 2017, 102:2179-2187. [22] Uvelius E, Höglund P, Valdemarsson S, Siesjö P. An early post-operative ACTH suppression test can safely predict short- and long-term remission after surgery of Cushing's disease[J]. Pituitary, 2018, 21:490-498. [23] Starke RM, Reames DL, Chen CJ, Laws ER, Jane JA Jr. Endoscopic transsphenoidal surgery for cushing disease:techniques, outcomes, and predictors of remission[J]. Neurosurgery, 2013, 72:240-247. [24] Blevins LS Jr, Christy JH, Khajavi M, Tindall GT. Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas[J]. J Clin Endocrinol Metab, 1998, 83:63-67. |